BACKGROUND: The goal of the present study was to evaluate the impact of delayed autologous breast reconstruction on disease relapse in breast cancer patients treated with mastectomy. MATERIAL AND METHODS: The study was based on 503 consecutive patients younger than 70 years of age who underwent mastectomy between January 2000 and December 2003. Overall, 391 (78 %) received mastectomy alone and 112 (22 %) underwent a delayed breast reconstruction. The median time from mastectomy to delayed breast reconstruction was 34 months. The median duration of follow-up was 102 months. RESULTS: There were no locoregional recurrences (LRR) in patients who underwent delayed reconstruction (0.0 %); 21 LRR developed in patients treated with mastectomy only (5.4 %), P = 0.011. Distant metastases occurred less frequently in the reconstruction group (12.5 %) than in the patients who underwent mastectomy alone (21.5 %); P = 0.0343. The 8-year breast cancer specific survival in the reconstruction group was 98.2 and 85.7 % for the mastectomy only group, P = 0.000. CONCLUSIONS: Delayed autologous breast reconstruction does not appear to adversely influence disease progression when compared to patients treated with mastectomy only.
BACKGROUND: The goal of the present study was to evaluate the impact of delayed autologous breast reconstruction on disease relapse in breast cancerpatients treated with mastectomy. MATERIAL AND METHODS: The study was based on 503 consecutive patients younger than 70 years of age who underwent mastectomy between January 2000 and December 2003. Overall, 391 (78 %) received mastectomy alone and 112 (22 %) underwent a delayed breast reconstruction. The median time from mastectomy to delayed breast reconstruction was 34 months. The median duration of follow-up was 102 months. RESULTS: There were no locoregional recurrences (LRR) in patients who underwent delayed reconstruction (0.0 %); 21 LRR developed in patients treated with mastectomy only (5.4 %), P = 0.011. Distant metastases occurred less frequently in the reconstruction group (12.5 %) than in the patients who underwent mastectomy alone (21.5 %); P = 0.0343. The 8-year breast cancer specific survival in the reconstruction group was 98.2 and 85.7 % for the mastectomy only group, P = 0.000. CONCLUSIONS: Delayed autologous breast reconstruction does not appear to adversely influence disease progression when compared to patients treated with mastectomy only.
Authors: Sharla Gayle Patterson; Paige Teller; Radha Iyengar; Grant W Carlson; Sheryl G A Gabram-Mendola; Albert Losken; Toncred Styblo; Mylin Torres; William C Wood; Sebastian D Perez; Marina Mosunjac; Monica Rizzo Journal: Ann Surg Oncol Date: 2012-04-03 Impact factor: 5.344
Authors: Sashank Reddy; Salih Colakoglu; Michael S Curtis; Janet H Yueh; Adeyemi Ogunleye; Adam M Tobias; Bernard T Lee Journal: Ann Plast Surg Date: 2011-05 Impact factor: 1.539
Authors: Min Yi; Steven J Kronowitz; Funda Meric-Bernstam; Barry W Feig; W Fraser Symmans; Anthony Lucci; Merrick I Ross; Gildy V Babiera; Henry M Kuerer; Kelly K Hunt Journal: Cancer Date: 2010-10-13 Impact factor: 6.860
Authors: Michael Bezuhly; Claire Temple; Leif J Sigurdson; Roger B Davis; Gordon Flowerdew; E Francis Cook Journal: Cancer Date: 2009-10-15 Impact factor: 6.860
Authors: Colleen M McCarthy; Andrea L Pusic; Lisa Sclafani; Claire Buchanan; Jane V Fey; Joseph J Disa; Babak J Mehrara; Peter G Cordeiro Journal: Plast Reconstr Surg Date: 2008-02 Impact factor: 4.730
Authors: Stephane Zervoudis; George Iatrakis; Eirini Tomara; Anastasia Bothou; George Papadopoulos; George Tsakiris Journal: World J Clin Oncol Date: 2014-08-10
Authors: Paymon Sanati-Mehrizy; Benjamin B Massenburg; John M Rozehnal; Nachi Gupta; Jonatan Hernandez Rosa; Michael J Ingargiola; Peter J Taub Journal: Eplasty Date: 2015-09-30
Authors: Hanna Dillekås; Romano Demicheli; Ilaria Ardoino; Svein A H Jensen; Elia Biganzoli; Oddbjørn Straume Journal: Breast Cancer Res Treat Date: 2016-06-15 Impact factor: 4.872
Authors: H Adam; A C Docherty Skogh; Å Edsander Nord; I Schultz; J Gahm; P Hall; J Frisell; M Halle; J de Boniface Journal: Br J Surg Date: 2018-04-23 Impact factor: 6.939
Authors: Claudia A Bargon; Danny A Young-Afat; Mehmet Ikinci; Assa Braakenburg; Hinne A Rakhorst; Marc A M Mureau; Helena M Verkooijen; Annemiek Doeksen Journal: Cancer Date: 2022-07-27 Impact factor: 6.921
Authors: Joachim Geers; Hans Wildiers; Katrien Van Calster; Annouschka Laenen; Giuseppe Floris; Marc Vandevoort; Gerd Fabre; Ines Nevelsteen; Ann Smeets Journal: BMC Cancer Date: 2018-10-19 Impact factor: 4.430